Stockreport

FDA enacts abbreviated approval pathway for insulin biosimilars [Seeking Alpha]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF Effective today, the FDA institutes a shortened regulatory pathway consider future marketing applications Selected tickers: Eli Lilly ( LLY -2.4% NVO +2.2% SNY +2.6% TEV [Read more]